ArticleCost effectiveness and resource allocation : C/E2025

A cost-utility analysis of long-acting insulin analogues (detemir, glargine and degludec) for the treatment of adult type 1 diabetes in South Africa.

Mark T Verryn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.